Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs-Reference-Cited by-同舟云学术

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

Published:2022-01-15 Issue:3 Volume:96 Page:859-875
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Madar-Balakirski Noa,Rosner Amir,Melamed Sharon,Politi Boaz,Steiner Michal,Tamir Hadas,Yahalom-Ronen Yfat,Bar-David Elad,Ben-Shmuel Amir,Sittner Assa,Glinert Itai,Weiss Shay,Bar-Haim Erez,Cohen Hila,Elia Uri,Achdout Hagit,Erez Noam,Rotem Shahar,Lazar Shlomi,Nyska Abraham,Yitzhaki Shmuel,Beth-Din Adi,Levy Haim,Paran Nir,Israely Tomer,Marcus Hadar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-021-03214-w.pdf

Reference36 articles.

1. Agrawal AS, Tao X, Algaissi A et al (2016) Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccin Immunother 12(9):2351–2356. https://doi.org/10.1080/21645515.2016.1177688

2. Baldrick P (2016) Dose site reactions and related findings after vaccine administration in safety studies. J Appl Toxicol 36(8):980–990. https://doi.org/10.1002/jat.3314

3. Corman VM, Landt O, Kaiser M et al (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045

4. Du L, Tai W, Zhou Y, Jiang S (2016) Vaccines for the prevention against the threat of MERS-CoV. Expert Rev Vaccines 15(9):1123–1134. https://doi.org/10.1586/14760584.2016.1167603

5. Farooq F, Beck K, Paolino KM et al (2016) Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep 6:27944. https://doi.org/10.1038/srep27944

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals;Archives of Toxicology;2024-09-03

2. Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine;Vaccines;2024-05-01

3. Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSVMT) in golden syrian hamster;Acta Pharmaceutica Sinica B;2023-12

4. VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants;Viruses;2023-06-13

5. Application of Nanotechnology in COVID-19 Infection: Findings and Limitations;Journal of Nanotheranostics;2022-11-02